Protalix BioTherapeutics Aktie
WKN DE: A0ML0E / ISIN: US74365A1016
|
09.05.2025 12:55:44
|
Protalix BioTherapeutics Inc. Q1 Loss Narrows
(RTTNews) - Protalix BioTherapeutics Inc. (PLX) released Loss for first quarter of -$3.62 million
The company's earnings came in at -$3.62 million, or -$0.05 per share. This compares with -$4.60 million, or -$0.06 per share, last year.
The company's revenue for the period rose 169.6% to $10.11 million from $3.75 million last year.
Protalix BioTherapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$3.62 Mln. vs. -$4.60 Mln. last year. -EPS: -$0.05 vs. -$0.06 last year. -Revenue: $10.11 Mln vs. $3.75 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Protalix BioTherapeutics Incmehr Nachrichten
| Keine Nachrichten verfügbar. |